Track the 제일바이오 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 제일바이오 has published 35 reports. The latest transaction was filed on 24 February 2026 (Sale). Among the most active insiders: 심광경. All data is free.
35
Insider Decl.
n/a
Thresholds
n/a
16 ops.
Buy Volume
n/a
4 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
제일바이오 is a healthcare and pharmaceutical company listed on the XKRX. It specializes in the development and manufacturing of biopharmaceutical products.